下一代粪便DNA检测：拓展范围 - Suppr

Suppr

超能文献

Next-generation stool DNA testing: expanding the scope.

作者信息

Ahlquist David A

机构信息

Miles and Shirley Fiterman Division of Gastroenterology and Hepatology, Rochester, Minnesota 55905, USA.

出版信息

Gastroenterology. 2009 Jun;136(7):2068-73. doi: 10.1053/j.gastro.2009.04.025. Epub 2009 Apr 18.

DOI:10.1053/j.gastro.2009.04.025

PMID:19379748

Abstract

摘要

相似文献

Next-generation stool DNA testing: expanding the scope.

Gastroenterology. 2009 Jun;136(7):2068-73. doi: 10.1053/j.gastro.2009.04.025. Epub 2009 Apr 18.

Stool DNA screening for colorectal cancer: opportunities to improve value with next generation tests.

J Clin Gastroenterol. 2011 Apr;45(4):301-8. doi: 10.1097/MCG.0b013e3181f0f028.

Screening with a fecal multitarget DNA test.

Gastroenterology. 2005 Aug;129(2):757-9; discussion 759. doi: 10.1016/j.gastro.2005.04.039.

Improved fecal DNA test for colorectal cancer screening.

Clin Gastroenterol Hepatol. 2007 Jan;5(1):111-7. doi: 10.1016/j.cgh.2006.10.006. Epub 2006 Dec 8.

Is stool DNA multitarget testing an unreliable strategy for colorectal cancer screening?

Gut. 2005 Jun;54(6):891. doi: 10.1136/gut.2005.066951.

Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates.

Pathology. 2012 Feb;44(2):80-8. doi: 10.1097/PAT.0b013e3283502fdf.

Stool-based DNA tests for colorectal cancer: clinical potential and early results.

Rev Gastroenterol Disord. 2002;2 Suppl 1:S20-6.

Stool test for colorectal cancer screening: what is going on?

Surg Oncol. 2007 Dec;16 Suppl 1:S43-5. doi: 10.1016/j.suronc.2007.10.034.

Fecal DNA analysis for colorectal cancer screening.

Technol Eval Cent Assess Program Exec Summ. 2014 Dec;29(8):1-2.

Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?

Nat Clin Pract Oncol. 2005 May;2(5):234-5. doi: 10.1038/ncponc0170.

引用本文的文献

A Simple and Highly Specific MassARRAY-Based Stool DNA Assay to Prioritize Follow-up Decisions in Fecal Immunochemical Test-Positive Individuals.

Cancers (Basel). 2019 Mar 25;11(3):423. doi: 10.3390/cancers11030423.

KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population.

Oncol Lett. 2017 May;13(5):3608-3616. doi: 10.3892/ol.2017.5889. Epub 2017 Mar 22.

Fecal Recovery of Ingested Cellular DNA: Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms.

Dig Dis Sci. 2016 Jan;61(1):117-25. doi: 10.1007/s10620-015-3845-z. Epub 2015 Aug 22.

Multi-target stool DNA test: a new high bar for noninvasive screening.

Dig Dis Sci. 2015 Mar;60(3):623-33. doi: 10.1007/s10620-014-3451-5. Epub 2014 Dec 10.

Patient perceptions of stool DNA testing for pan-digestive cancer screening: a survey questionnaire.

World J Gastroenterol. 2014 May 7;20(17):4972-9. doi: 10.3748/wjg.v20.i17.4972.

Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions.

BMJ Open. 2013 Oct 30;3(10):e003989. doi: 10.1136/bmjopen-2013-003989.

Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies.

Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):594-600. doi: 10.1158/1055-9965.EPI-11-1060. Epub 2012 Feb 7.

Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates.

Cancer. 2012 May 15;118(10):2623-31. doi: 10.1002/cncr.26558. Epub 2011 Sep 22.

Next-generation stool DNA test accurately detects colorectal cancer and large adenomas.

Gastroenterology. 2012 Feb;142(2):248-56; quiz e25-6. doi: 10.1053/j.gastro.2011.10.031. Epub 2011 Nov 4.

Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract.

CMAJ. 2011 Sep 20;183(13):1474-81. doi: 10.1503/cmaj.101248. Epub 2011 Aug 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Next-generation stool DNA testing: expanding the scope.

作者信息

Ahlquist David A

机构信息

Miles and Shirley Fiterman Division of Gastroenterology and Hepatology, Rochester, Minnesota 55905, USA.

出版信息

Gastroenterology. 2009 Jun;136(7):2068-73. doi: 10.1053/j.gastro.2009.04.025. Epub 2009 Apr 18.

DOI:10.1053/j.gastro.2009.04.025

PMID:19379748

Abstract

摘要

相似文献

Next-generation stool DNA testing: expanding the scope.

Gastroenterology. 2009 Jun;136(7):2068-73. doi: 10.1053/j.gastro.2009.04.025. Epub 2009 Apr 18.

Stool DNA screening for colorectal cancer: opportunities to improve value with next generation tests.

J Clin Gastroenterol. 2011 Apr;45(4):301-8. doi: 10.1097/MCG.0b013e3181f0f028.

Screening with a fecal multitarget DNA test.

Gastroenterology. 2005 Aug;129(2):757-9; discussion 759. doi: 10.1016/j.gastro.2005.04.039.

Improved fecal DNA test for colorectal cancer screening.

Clin Gastroenterol Hepatol. 2007 Jan;5(1):111-7. doi: 10.1016/j.cgh.2006.10.006. Epub 2006 Dec 8.

Is stool DNA multitarget testing an unreliable strategy for colorectal cancer screening?

Gut. 2005 Jun;54(6):891. doi: 10.1136/gut.2005.066951.

Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates.

Pathology. 2012 Feb;44(2):80-8. doi: 10.1097/PAT.0b013e3283502fdf.

Stool-based DNA tests for colorectal cancer: clinical potential and early results.

Rev Gastroenterol Disord. 2002;2 Suppl 1:S20-6.

Stool test for colorectal cancer screening: what is going on?

Surg Oncol. 2007 Dec;16 Suppl 1:S43-5. doi: 10.1016/j.suronc.2007.10.034.

Fecal DNA analysis for colorectal cancer screening.

Technol Eval Cent Assess Program Exec Summ. 2014 Dec;29(8):1-2.

Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?

Nat Clin Pract Oncol. 2005 May;2(5):234-5. doi: 10.1038/ncponc0170.

引用本文的文献

A Simple and Highly Specific MassARRAY-Based Stool DNA Assay to Prioritize Follow-up Decisions in Fecal Immunochemical Test-Positive Individuals.

Cancers (Basel). 2019 Mar 25;11(3):423. doi: 10.3390/cancers11030423.

KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population.

Oncol Lett. 2017 May;13(5):3608-3616. doi: 10.3892/ol.2017.5889. Epub 2017 Mar 22.

Fecal Recovery of Ingested Cellular DNA: Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms.

Dig Dis Sci. 2016 Jan;61(1):117-25. doi: 10.1007/s10620-015-3845-z. Epub 2015 Aug 22.

Multi-target stool DNA test: a new high bar for noninvasive screening.

Dig Dis Sci. 2015 Mar;60(3):623-33. doi: 10.1007/s10620-014-3451-5. Epub 2014 Dec 10.

Patient perceptions of stool DNA testing for pan-digestive cancer screening: a survey questionnaire.

World J Gastroenterol. 2014 May 7;20(17):4972-9. doi: 10.3748/wjg.v20.i17.4972.

Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions.

BMJ Open. 2013 Oct 30;3(10):e003989. doi: 10.1136/bmjopen-2013-003989.

Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies.

Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):594-600. doi: 10.1158/1055-9965.EPI-11-1060. Epub 2012 Feb 7.

Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates.

Cancer. 2012 May 15;118(10):2623-31. doi: 10.1002/cncr.26558. Epub 2011 Sep 22.

Next-generation stool DNA test accurately detects colorectal cancer and large adenomas.

Gastroenterology. 2012 Feb;142(2):248-56; quiz e25-6. doi: 10.1053/j.gastro.2011.10.031. Epub 2011 Nov 4.

Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract.

CMAJ. 2011 Sep 20;183(13):1474-81. doi: 10.1503/cmaj.101248. Epub 2011 Aug 2.